CK-8 Polyclonal Antibody

Background:
Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.

Research Area: Cancer, Signal Transduction

Synonyms:
CARD2, CK 8, CK-8, CK8, CYK8, CYKER, Cytokeratin endo A, Cytokeratin-8, DreK8, EndoA, K2C8, K2C8, K8, Keratin 8, Keratin type II cytoskeletal 8, Keratin, type II cytoskeletal 8, Keratin-8, KO, Krt 2.8, KRT8, MGC118110, MGC174782, MGC53564, MGC85764, sb:cb186, Type-II keratin Kb8

Immunogen: KLH conjugated Synthetic peptide corresponding to Mouse Cytokeratin 8

Swissprot: P05787,P11679,Q10758

Calculated MW: 54 kDa
Observed MW: 54 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.02% sodium azide, 1% BSA and 50% glycerol, pH7.4

Concentration: 430 μg/mL
Dilution: WB 1:500-1:2000, IHC 1:200-1:800

Storage:
Store at -20°C. Avoid freeze / thaw cycles.